Kane Biotech Inc.
KNBIF
$0.0643
-$0.002-3.02%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -444.20K | 6.71M | -1.04M | -1.13M | -1.03M |
| Total Depreciation and Amortization | 34.00K | 39.70K | 40.10K | 41.10K | 44.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.00K | -7.53M | 156.90K | -471.10K | 495.70K |
| Change in Net Operating Assets | -80.40K | -801.10K | 108.30K | 152.10K | -46.00K |
| Cash from Operations | -394.50K | -1.59M | -730.00K | -1.40M | -533.30K |
| Capital Expenditure | -3.70K | -7.50K | -3.80K | -4.70K | -2.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 6.99M | -- | -- | -- |
| Other Investing Activities | -2.50K | -375.70K | -3.90K | -3.20K | -22.40K |
| Cash from Investing | -6.20K | 6.61M | -7.70K | -7.90K | -24.40K |
| Total Debt Issued | -- | -- | -- | 0.00 | 1.00M |
| Total Debt Repaid | -153.90K | -6.15M | -193.10K | -152.60K | -152.30K |
| Issuance of Common Stock | 248.70K | -- | -- | -16.20K | 415.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.80K | -1.42M | 1.00M | 1.24M | -37.90K |
| Cash from Financing | 59.40K | -5.53M | 600.50K | 764.60K | 913.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -341.30K | -507.10K | -137.10K | -647.80K | 355.70K |
